From the Journals
News
CTE common among young athletes in largest brain donor study
“A lot of people think CTE is a result of high-level, professional play such as football, ice hockey, and boxing, but it can affect amateur...
From the Journals
Severe COVID may cause long-term cellular changes: Study
This study shows that after severe COVID, the immune system remains in ‘emergency mode’ and in a heightened state of inflammation.
From the Journals
AAP’s hearing test clinical update is the first since 2009
Guidance updates developmental milestones and screening recommendations and changes terminology to eliminate references such as “failed” and “...
From the Journals
Post-SCT, better survival in children with healthy gut diversity
After donor stem cell transplants, children with lower gut microbiota diversity show poorer survival and more complications.
Guidelines
First guidelines developed for childhood eosinophilic GI disorders beyond eosinophilic esophagitis
“Our ability to say: ‘Here are the established treatments,’ is lacking, though. We need research studies to verify that our recommended approaches...
From the Journals
Long COVID leads to greater health risks, research finds
“There was really nothing at all looking at what happens to people at 2 years after the infection. So we decided to take a look.”
Latest News
Type 1 diabetes management improves as technology advances
Automated insulin delivery systems have reduced A1c levels, but many still are not achieving numbers under 7%.
Latest News
Marijuana, hallucinogen use, binge drinking at all-time high
The biggest increases have been in the adult cohort aged 35-50 years.
From the Journals
Getting COVID shots in same arm may be more effective, study says
There’s greater immunological response if the immune cells in the lymph nodes are restimulated in the same place, according to one expert.
From the Journals
Delayed introduction of allergens increases allergy risk
The findings confirm the importance of not delaying the introduction of major food allergens to prevent the occurrence of childhood allergic...
From the Journals
FDA approves first RSV vaccine for pregnancy
The vaccine can be given between weeks 32 and 36 of pregnancy and is designed to protect infants from the virus from birth to 6 months of age.